|
|
1. Diabetes, Lipids
and Atherosclerosis
September 14-16, 2000
| Friday,
September 15, 2000 |
| 08:30-08:40
|
Introduction
T. A. Herskovits, Israel |
| 08:40-09:00
|
Welcome Remarks
S.M. Shasha, Director, Western Galilee Hospital - Nahariya, Israel
J. Sabag, Mayor of Nahariya, Israel
I. Raz, President, Israel Diabetes Association, Israel |
| 09:00-09:10
|
Opening Remarks
H. Bar-On, Israel |
| MORNING
SESSION: ENDOTHELIAL DYSFUNCTION AND ATHEROGENESIS IN DIABETES |
| Chairperson:
G. H. Tomkin, Ireland |
| 09:10-09:40
|
Insulin Resistance and Vascular Function in
Diabetes
H. Yki-Jarvinen, Finland |
| 09:40-10:20
|
How to Evaluate Endothelial Function in Vivo
J. Cockroft, UK |
| 10:20-10:50
|
Coffee Break and Visit to
Exhibitions |
| Chairperson:
G. Steiner, Canada |
| 10:50-11:30
|
Oxidative Stress in Diabetes
N. A. Chait, USA |
| 11:30-12:00
|
Contribution of Peripheral Polymorphonuclear
Leukocytes to Oxidative Stress and Inflammation
B. Kristal, Israel |
| 12:00-12:40
|
Intensive Lipid Lowering in Diabetes,
Vascular Consequences
J.D. Banga, UK |
| 12:40-13:40
|
Lunch Break and Visit to Exhibitions |
| AFTERNOON
SESSION: DIABETIC DYSLIPIDEMIA - NEW INSIGHTS AND MANAGEMENT |
| Chairperson:
H. Bar-On, Israel |
| 13:40-14:20
|
Mechanisms and Management of
Hyperlipidemia in Diabetes
R. Goldberg, USA |
| 14:20-15:00
|
Regulation of VLDL Metabolism
M. R. Taskinen, Finland |
| 14:50-15:20
|
Coffee Break and Visit to
Exhibitions |
| Chairperson:
T. A. Herskovits, Israel |
| 15:20-16:00
|
Atherogenic Lipoprotein Phenotype in Type 2
Diabetes: Effect of Fenofibrate Treatment
M. Feher, UK |
| 16:00-16:30
|
Clinical Trials in Diabetes
Dyslipidemia
A. Rubinstein, Israel |
| 16:30-17:00
|
Closing Remarks and General Discussion
G. Steiner, Canada and
G. H. Tomkin, Ireland |
Western Galilee Hospital - Nahariya
Hanoch Bar-On, Israel
Tommy A. Herskovits, Israel
Israel Diabetes Association
Municipality of Nahariya, Israel
Aventis Pharma, Israel
Agis, Israel
Bayer, Israel
Dexxon, Israel
Eli Lilly Israel Ltd., Israel
Janssen-Cilag, Israel
MSD, Israel
Neopharm, Israel
Novo Nordisk, Israel
Roche Pharmaceuticals, Israel
Smith Kline Beecham, Israel
Soglowek Food Industry, Israel
Strauss Dairies Ltd., Israel
Teva Pharmaceuticals, Israel
 FOR
GENERAL, REGISTRATION AND ACCOMMODATION ENQUIRIES
Prof. Hanoch Bar-On
Tel: +972 2677 6967
Fax: +972 2 641 8186
Email: baron@hadassah.org.il
OR
Dr. Tommy A. Herskovits
Tel: +972 4 985 0558/9
Fax: +972 4 985 0559
Email: tommyh@inter.net.il
|
